Adzenys Er

Active Ingredient(s): Amphetamine
FDA Approved: * September 15, 2017
Pharm Company: * NEOS THERAPS INC
Category: ADD / ADHD

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Adzenys Er Overview

Amphetamine[note 1] (contracted from alpha-methylphenethylamine) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine was discovered in 1887 and exists as two enantiomers:[note 2] levoamphetamine and dextroamphetamine. Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers, levoamphetamine and dextroamphetamine, in...

Read more Adzenys Er Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amphetamine

Recent Adzenys Er Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Adzenys Er: (1 result)

Sorted by National Drug Code

• 70165-003 Adzenys ER 1.25 mg/ml Oral Suspension, Extended Release by Neos Therapeutics, Lp

Other drugs which contain Amphetamine or a similar ingredient: (19 results)

Related Adzenys Er Topics: